Serum Uric Acid: An Independent Risk Factor for Cardiovascular

Does uric acid qualify as an independent risk factor for cardiovascular mortality?

UA (uric acid) is the final product of purine metabolism in humans and is implicated in many disease conditions. Sustained hyperuricaemia has putative adverse roles in cardiovascular diseases. Despite strong evidence emerging from large epidemiological studies supporting the hypothesis that UA independently influences cardiovascular disease outcomes and mortality, a causal role is yet to be est...

Serum uric acid level is an independent risk factor for cardiovascular disease in middle-aged and elderly Chinese individuals

Department of Endocrinology, Xinhua hospital, School of medicine, Shanghai Jiaotong University, Shanghai, China Department of Endocrinology, Xinhua hospital Chongming branch, School of medicine, Shanghai Jiaotong University, Shanghai, China Shanghai Municipal Center For Disease Control And Prevention, Shanghai, China Department of Endocrinology, Ruijin hospital, School of medicine, Shanghai Jia...

Serum uric Acid is not an independent risk factor for premature coronary artery disease.

BACKGROUND/AIM There is still debate on the role of serum uric acid as an independent risk factor for coronary artery disease (CAD), particularly premature CAD. This study aimed to investigate whether serum uric acid is a risk factor for premature CAD and whether it can influence the severity of coronary artery stenosis. METHODS Candidates for coronary artery angiography (age <45 years for me...

Uric acid and cardiovascular risk.

Copyright © 2008 Massachusetts Medical Society. An association of gout with hypertension, diabetes, kidney disease, and cardiovascular disease has been observed since the late 19th century. Early investigators, such as Frederick Mahomed, Alexander Haig, and Nathan Smith Davis, hypothesized that uric acid might be a cause of hypertension or renal disease. In 1897, in his presidential address to ...

Serum uric acid and cardiovascular disease.